Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model.

被引：0

作者：

Ciccone, David ^{[1
]}

Lazari, Vad ^{[2
]}

Linney, Ian ^{[2
]}

Briggs, Michael ^{[2
]}

Carreiro, Samantha ^{[1
]}

Loh, Christine ^{[1
]}

Tummino, Peter ^{[1
]}

McElwee, Joshua ^{[1
]}

Collis, Alan ^{[1
]}

Kaila, Neelu ^{[1
]}

机构：

[1] Nimbus Therapeut, Cambridge, MA USA

[2] Charles River Labs, Chesterford Res Pk, Saffron Walden, Essex, England

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1649

引用

页数：1

共 50 条

[21] Inhibition of the Wnt/β-catenin pathway to promote T-cell immunity and survival in a syngeneic mouse model of ovarian cancer.
Doo, David W.
Londono, Angelina
Meza-Perez, Selene
Katre, Ashwini A.
Cooper, Sara J.
Straughn, John Michael
Buchsbaum, Donald J.
Norian, Lyse
Randall, Troy
Arend, Rebecca Christian
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[22] Inhibition of MMP9 improves anti-tumor immunity by changing the tumor microenvironment to promote T cell trafficking and activation
Juric, Vladi
Mikels-Vigdal, Amanda
O'Sullivan, Chris
Greenstein, Andrew
Stefanutti, Erin
Barry-Hamilton, Vivian
Mikaelian, Igor
Sullivan, Ted
Huntzicker, Erik
Degenhardt, Jeremiah
Yue, Peng
Smith, Victoria
CANCER RESEARCH, 2017, 77
[23] ANALYSIS OF HUMAN LYMPHOCYTE-T ACTIVATION IN A T-CELL TUMOR-MODEL SYSTEM
LANDEGREN, U
ANDERSSON, J
WIGZELL, H
EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (03) : 308 - 311
[24] Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks
Xu, L.
Feng, J-M
Li, J-X
Zhu, J-M
Song, S-S
Tong, L-J
Chen, Y.
Yang, X-Y
Shen, Y-Y
Lian, F-L
Li, Y-P
Lin, D-H
Ding, J.
Miao, Z-H
CELL DEATH & DISEASE, 2013, 4 : e905 - e905
[25] Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks
L Xu
J-M Feng
J-X Li
J-M Zhu
S-S Song
L-J Tong
Y Chen
X-Y Yang
Y-Y Shen
F-L Lian
Y-P Li
D-H Lin
J Ding
Z-H Miao
Cell Death & Disease, 2013, 4 : e905 - e905
[26] PGC-1α engineered CD8 T cell for enhanced anti-tumor immunity
Dumauthioz, Nina
Tschumi, Benjamin
Wenes, Mathias
Wang, Haiping
Franco, Fabien
Lopez-Mejia, Isabel
Fajas, Lluis
Ho, Ping-Chih
Donda, Alena
Romero, Pedro
Zhang, Lianjun
SWISS MEDICAL WEEKLY, 2019, : 23S - 24S
[27] Eupatorin Suppressed Tumor Progression and Enhanced Immunity in a 4T1 Murine Breast Cancer Model
Abd Razak, Nursyamirah
Yeap, Swee Keong
Alitheen, Noorjahan Banu
Ho, Wan Yong
Yong, Chean Yeah
Tan, Sheau Wei
Tan, Wen Siang
Long, Kamariah
INTEGRATIVE CANCER THERAPIES, 2020, 19
[28] Enhanced cytotoxic T-cell function and inhibition of tumor progression by Mst1 deficiency
Yasuda, Kaneki
Ueda, Yoshihiro
Ozawa, Madoka
Matsuda, Tadashi
Kinashi, Tatsuo
FEBS LETTERS, 2016, 590 (01): : 68 - 75
[29] MAP4K1 inhibition enhances immune cell activation and anti-tumor immunity in preclinical tumor models.
Faia, Kerrie
Toso, Alberto
Fetalvero, Kristina
Roche, Marly
Bench, Steven
O'Hearn, Erin
Cao, Qiongfang
Bright, Kerry-Ann
Paduraru, Debora
Romagnani, Andrea
Weng, Weifan
Zimmermann, Tina
Burke, Michael
Close, Joshua
Green, Luke
Kim, Joseph
Miduturu, Chandra
Ribeiro, Alison
Bacac, Marina
Herter, Sylvia
Perola, Emanuele
Sheets, Michael
Eckmann, Jan
Heidkamp, Gordon
Traore, Tary
Gerson, Erik
Woessner, Rich
Wolter, Carsten
Scheuplein, Felix
Perez, Nisha
LaBranche, Timothy
Silva, Grace
Ye, Chaoyang
Utt, Caitlin
Gross, Stefan
Bischoff, James R.
Dorsch, Marion
Guzi, Tim
Hoeflich, Klaus
Brubaker, Jason
CANCER RESEARCH, 2021, 81 (13)
[30] Enhanced Expression Of Program Death Ligand-1 (pdl-1) Indicates Significant Inhibition Of Tumor Associated T Cells Immunity
Doddamreddy, P.
Vijay, D.
Tang, E.
Upadhyay, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191

← 1 2 3 4 5 →